Home Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
Article Open Access

Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane

  • Qian Li EMAIL logo and Hu Zhang
Published/Copyright: September 26, 2023

Abstract

Pulmonary arterial hypertension (PAH) is a rapidly progressing cardiopulmonary disease. It is characterized by increased pulmonary artery pressure and vascular resistance. The most notable histopathological characteristic is vascular remodeling. The changes in the basement membrane (BM) are believed to be related to vascular remodeling. It is crucial to identify potential biomarkers associated with the BM in PAH, to guide its treatment. The microarray datasets GSE117261 and GSE113439 were downloaded from the Gene Expression Omnibus. Two data sets were examined to identify genes associated with the BM by analyzing gene expression changes. Next, we analyzed the relevant genes in the Kyoto Encyclopedia of Genes and Genomes using Gene Ontology and Disease Ontology annotationand conducted pathway enrichment analysis. We conducted a protein–protein interaction network analysis on the genes related to BMs and used the cell cytoHubba plug-in to identify the hub genes. Furthermore, we conducted an immune infiltration analysis and implemented a histogram model. Finally, we predicted and analyzed potential therapeutic drugs for PAH and set up a miRNA network of genetic markers. Six candidate genes related to BMs, namely Integrin Subunit Alpha V, Integrin Subunit Alpha 4, ITGA2, ITGA9, Thrombospondin 1, and Collagen Type IV Alpha 3 Chain, were identified as potential modulators of the immune process in PAH. Furthermore, ginsenoside Rh1 was found to significantly impact drug targeting based on its interactions with the six BM-related genes identified earlier. A novel biomarker related to the BM, which plays a crucial role in the development of PAH, has been identified.

1 Introduction

Pulmonary arterial hypertension (PAH) is a severe pulmonary vascular condition. It differs from hypertension. Hypertension is an increase in blood pressure resulting from increased arterial vascular resistance or decreased cardiac pumping activity. It is typically expressed as systolic blood pressure (diastolic blood pressure) ≥140 (90) mmHg, while PAH is caused by an increase in pulmonary vascular resistance or a decrease in pulmonary blood flow [1,2]. The primary histopathological characteristic of PAH is vascular remodeling. This leads to increased right ventricular afterload and may result in the disease rapidly advancing to heart failure [3,4]. Currently, the clinical treatment of PAH relies on drug therapy, including calcium antagonists, angiotensin-converting enzyme inhibitors, and prostaglandin drugs, among others [5,6]. These drugs primarily inhibit pulmonary vasoconstriction and control symptoms but have a limited impact on pulmonary vascular remodeling. Individuals with PAH typically have an unfavorable long-term outlook. Recent studies indicate that pulmonary vascular remodeling has a significant impact on PAH. Consequently, inhibiting or delaying the process has become a crucial strategy in the development of therapeutic drugs for the condition [7].

During the early stages of PAH formation, endothelial cells (ECs) can undergo damage and apoptosis. However, as the disease progresses, ECs seem to become resistant to apoptosis [8]. During the advanced stages of PAH, many ECs undergo excessive proliferation and accumulate anti-apoptotic properties. This accumulation eventually leads to the formation of plexiform lesions that can destroy the normal vascular structure [9]. The basement membrane (BM) is a special extracellular matrix (ECM), which is mainly composed of type IV collagen, laminin, proteoglycans (including BM heparin sulfate proteoglycans and other glycoproteins), and so on [10]. Laminin is the primary structural protein of the BM and is mainly responsible for the adhesion of epithelial cells to BM. Collagen type IV is a collagen that is specific to the BM and forms the structural scaffold of the BM. Proteoglycan is a complex long-chain glycoprotein with a high negative charge. This protein regulates the negative charge and biological properties of the BM and participates in signal transduction [10,11]. Therefore, BM ensures the integrity and stability of the vascular structure by preserving the normal positional relationship between the cells of the vascular wall and the ECM. Alterations in the BM have been observed in lung disorders that are distinguished by vascular remodeling and pulmonary hypertension [12]. Recent studies indicate a possible link between autoimmune diseases and autoantibody attacks against BM proteins. Furthermore, the expression and variation of BM have been found to significantly impact the development of PAH [13].

Bioinformatics research has been employed to investigate the possible pathogenetic factors for cardiovascular disease [14]. Pathogenic factors may include genetic susceptibility, with vascular lesions potentially caused by abnormalities in certain pathological genes and signaling pathways [15]. The mechanism of immune inflammation and the vascular inflammatory response is mediated by inflammatory factors and immune cells [16]. Vascular damage causes metabolic syndrome, obesity, insulin resistance, and other related metabolic disorders [17]. Currently, bioinformatics research in the PAH field is concentrated on mRNA expression profiling, exploring the molecular mechanisms underlying PAH, and identifying biomarkers through changes in gene expression in PAH patients. Ma et al. [18] found that 150 differently expressed genes (DEGs) of PAH were identified by Gene Expression Omnibus (GEO). It is speculated that Structural Maintenance of Chromosomes 2 (SMC2), DNA Topoisomerase II Alpha, SMC2, KIF23, and other targets may be involved in the pathogenesis of PAH, and the potential molecular mechanism of PAH provides new evidence. Nevertheless, there is currently no confirmed relationship between the BM genes and the pathogenesis of PAH. This is the first bioinformatics technique to identify the interaction between the hub genes of BM and lung tissue, which offers a novel viewpoint and reference for the management and treatment of PAH.

2 Materials and methods

2.1 Acquisition of genes associated with the BM through microarray data analysis

Gene expression data and microarray platform information for pulmonary tissues of PAH and normal controls (NC) were collected from the GEO database (https://www.ncbi.nlm.nih.gov/geo/) using the search term “Pulmonary Arterial Hypertension.” The criteria for data inclusion were: (a) the organism was of Homo sapiens origin, (b) all NC and pulmonary tissue samples had comprehensive data, and (c) the samples included both control and pulmonary tissues. We only analyzed datasets that met these criteria. Therefore, we included two datasets, GSE117261 and GSE113439, which exhibited similarities in their sequencing methods. A search of the literature resulted in the identification of 224 genes associated with BM for this experiment [19].

2.2 A screening of genes related to BM associated with PAH

The “sva” and “affy” R packages were used to standardize the downloaded sample data, which was then aggregated. After that, normalization and log2 transformation procedures were performed. We obtained gene expression data for BM from two distinct datasets and conducted a differential expression analysis using the “Limma” package. This investigation considered |log2FC| > 0.2 and adj. P.Val < 0.05 as statistically significant. The analysis of differential expression was categorized based on the sample type, which consisted of PAH and NC.

2.3 Analysis of gene enrichment related to the BM in PAH

We evaluated the biofunctionality of Gene Ontology (GO), the occurrence of Disease Ontology (DO) disease, and the enrichment of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. The “clusterProfiler” package in the R program was used to visualize the DEGs. The significance threshold was set at an adjusted P value of less than 0.05.

2.4 Construction of protein–protein interaction (PPI) network and identification of hub genes

The STRING tool was used to explore the PPI network of BM-associated genes in PAH [20]. Moreover, the interactions between biological molecules associated with PAH were visualized and analyzed via the Cytoscape software [21]. CytoHubba plug-in in Cytoscape software was used to calculate the number of nodes and edges in the PPI network and obtain the maximum clique centrality (MCC) value, Degree value, and other parameters of each node. In this study, the top 10 genes with the highest Degree were selected as hub genes.

2.5 Immunoassay of BM-related genes

The presence of 16 different immune cell types and the activity of 13 immune-related pathways in every patient with PAH were examined using the single sample gene set enrichment analysis (ssGSEA) method provided by the “gsva” R package [22]. Initially, we collected gene sets for 16 immune cells, such as T cells, B cells, natural killer cells, and macrophages, from the ImmPort database. In addition, we collected gene sets for 13 immune-related pathways, such as the TNF-α signaling pathway and the T-cell receptor signaling pathway, from the KEGG database. Subsequently, we quantified the level of immune infiltration of 16 immune cells in each sample using the ssGSEA method. Similarly, we quantified the enrichment scores for the 13 immune-related functional pathways in each sample using the ssGSEA method. Correlation analysis was performed using the Spearman correlation analysis; P < 0.05 represents a significant correlation.

2.6 Nomogram design and validation

To assess the impact of the hub gene on survival in patients with PAH, we constructed a nomogram model. The nomogram was generated using the R package “rms” and the R package “ROCR” was used to evaluate the predictive power of the model. These packages considered risk scores and the expression of genes linked to the BM.

2.7 Prediction of drugs and miRNAs for genes associated with the BM

The Enrichr database [23] (https://maayanlabcloud/Enrichr/) was used to screen for genes related to pulmonary hypertension and BM based on a pharmacological prediction threshold of P < 0.05. To investigate miRNA–mRNA associations within the competing endogenous RNA (ceRNA) network further, we used the Enrichr database to identify possible miRNAs that could target the Hub genes. Next, a network diagram of the ceRNA system was constructed using Cytoscape software.

3 Results

3.1 Analysis of genes exhibiting differential expression in PAH

We downloaded the original expression profiles for patients with PAH for GSE117261 and GSE113439 from the GEO database. The GSE11726 dataset comprised 58 samples of PAH and 25 samples of normal lung (NC) tissue. The GSE113439 dataset contained 15 samples of PAH and 11 samples of NC tissue. We merged 36 NC samples and 73 PAH samples from two datasets, GSE117261 and GSE113439. In addition, we compared the genes related to BM with those related to PAH and conducted further analysis using criteria of |log2FC| > 0.2 and adj. P.Val < 0.05. Following this, the differential analysis showed that 53 DEGs, of which 36 upregulated genes and 17 downregulated genes, were differentially expressed between PAH samples and NC samples (refer to Figure 1a and b).

Figure 1 
                  An analysis of DEGs in the BM between PAH and control samples was conducted. (a) Each row of the heat map represents one DEG, while each column represents a sample, which is either normal or PAH. The color red denotes upregulated DEGs and green denotes downregulated DEGs. (b) The red points represent upregulated genes, while the green points represent downregulated genes. Abbreviations: DEG, differentially expressed gene; PAH, pulmonary artery hypertension.
Figure 1

An analysis of DEGs in the BM between PAH and control samples was conducted. (a) Each row of the heat map represents one DEG, while each column represents a sample, which is either normal or PAH. The color red denotes upregulated DEGs and green denotes downregulated DEGs. (b) The red points represent upregulated genes, while the green points represent downregulated genes. Abbreviations: DEG, differentially expressed gene; PAH, pulmonary artery hypertension.

3.2 BM-related gene enrichment analysis

Functional annotation of differential genes was performed, as shown in Figure 2. From the GO functional enrichment analysis, it was found that the DEGs involved in biological processes mainly included ECM organization, extracellular structure organization, external encapsulating structure organization, cell–substrate adhesion, and cell–matrix adhesion; the molecular components included collagen-containing ECM, BM, integrin complex, protein complex involved in cell adhesion, and lysosomal lumen; and the molecular functions included ECM structural constituent, integrin binding, glycosaminoglycan binding, collagen binding, and ECM binding (as shown in Figure 2a). BM-DEGs were found to be significantly enriched in myocardial infarction, bone sarcoma, bone cancer, and connective tissue cancer in DO enrichment analysis (Figure 2b). According to the results of KEGG enrichment analysis, BM-DEGs were mainly enriched in ECM–receptor interaction, focal adhesion, human papillomavirus infection, phosphoinositide 3-kinase (PI3K)-Akt signaling pathway, and the regulation of actin cytoskeleton (as shown in Figure 2c). Further information regarding the enrichment analysis can be found in Table 1.

Figure 2 
                  Enrichment analysis graph. (a) GO functional enrichment analysis; (b) DO disease enrichment analysis; and (c) KEGG pathway enrichment analysis.
Figure 2

Enrichment analysis graph. (a) GO functional enrichment analysis; (b) DO disease enrichment analysis; and (c) KEGG pathway enrichment analysis.

Table 1

Enrichment analysis notes

Category ID Description P value
BP GO:0030198 ECM organization 2.22 × 10−22
BP GO:0043062 Extracellular structure organization 2.36 × 10−22
BP GO:0045229 External encapsulating structure organization 2.68 × 10−22
BP GO:0031589 Cell–substrate adhesion 4.35 × 10−21
BP GO:0007160 Cell–matrix adhesion 8.31 × 10−17
CC GO:0062023 Collagen-containing ECM 7.08 × 10−44
CC GO:0005604 BM 5.17 × 10−25
CC GO:0008305 Integrin complex 3.15 × 10−19
CC GO:0098636 Protein complex involved in cell adhesion 1.08 × 10−16
CC GO:0043202 Lysosomal lumen 7.32 × 10−09
MF GO:0005201 ECM structural constituent 8.87 × 10−28
MF GO:0005178 Integrin binding 4.09 × 10−23
MF GO:0005518 Collagen binding 1.68 × 10−11
MF GO:0050840 ECM binding 1.95 × 10−10
MF GO:0005539 Glycosaminoglycan binding 1.01 × 10−09
DO DOID:0080639 Bone sarcoma 2.78 × 10−06
DO DOID:184 Bone cancer 3.94 × 10−06
DO DOID:854 Collagen disease 4.98 × 10−06
DO DOID:3347 Osteosarcoma 7.49 × 10−06
DO DOID:3627 Aortic aneurysm 9.93 × 10−06
DO DOID:520 Aortic disease 1.15 × 10−05
DO DOID:5844 Myocardial infarction 2.38 × 10−05
DO DOID:201 Connective tissue cancer 4.77 × 10−05
DO DOID:8947 Diabetic retinopathy 6.64 × 10−05
DO DOID:3376 Bone osteosarcoma 7.43 × 10−05
KEGG hsa04512 ECM–receptor interaction 2.44 × 10−25
KEGG hsa04510 Focal adhesion 2.57 × 10−14
KEGG hsa05165 Human papillomavirus infection 2.42 × 10−11
KEGG hsa04151 PI3K–Akt signaling pathway 5.97 × 10−11
KEGG hsa04810 Regulation of actin cytoskeleton 2.31 × 10−08
KEGG hsa05412 Arrhythmogenic right ventricular cardiomyopathy 2.62 × 10−08
KEGG hsa05410 Hypertrophic cardiomyopathy 7.81 × 10−08
KEGG hsa05414 Dilated cardiomyopathy 1.22 × 10−07
KEGG hsa05205 Proteoglycans in cancer 1.72 × 10−06
KEGG hsa05222 Small cell lung cancer 2.09 × 10−06

Abbreviations: GO, Gene Ontology; BP, biological process; CC: cellular component; MF: molecular function; DO, Disease Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes.

3.3 PPI networks

To develop a deeper understanding of the correlation between BM-DEGs, a PPI network analysis was carried out. Figure 3 shows the resulting network consisting of 53 nodes, 272 edges, and an average node degree of 10.3. We used the cytoHubba algorithm to identify 10 hub genes: These hub genes are Integrin Subunit Alpha V (ITGAV), ITGB3, ITGA9, ITGB8, THBS2, Integrin Subunit Alpha 4 (ITGA4), ITGA2, ITGA10, Collagen Type IV Alpha 3 Chain (COL4A3), and Thrombospondin 1 (THBS1). All of the 10 genes mentioned above have MCC and degree values that are higher than the average value of all nodes in the network diagram.

Figure 3 
                  PPI network construction and hub gene screening. (a) The PPI network of DEGs was depicted using the Cytoscape software. Upregulated genes were labeled in red, and downregulated genes were labeled in green. (b) Ten hub genes were screened using the cytoHubba plug-in. Abbreviations: DEGs, differently expressed genes; PPI: protein–protein interaction.
Figure 3

PPI network construction and hub gene screening. (a) The PPI network of DEGs was depicted using the Cytoscape software. Upregulated genes were labeled in red, and downregulated genes were labeled in green. (b) Ten hub genes were screened using the cytoHubba plug-in. Abbreviations: DEGs, differently expressed genes; PPI: protein–protein interaction.

3.4 Analysis of the immune cells and immune responses related to genes associated with the BM

To investigate the immune status variations of hub genes in PAH, we divided the PAH dataset into two groups: NC and PAH. Afterwards, we evaluated the enrichment scores of immune cells and immune-related functional pathways for both groups. Figure 4a and b shows a positive correlation between B cells and both tumor-infiltrating lymphocytes (TIL) (r = 0.76) and follicular helper T cells (Tfh) (r = 0.72). In contrast, mast cells exhibited a negative correlation with both macrophages (r = 0.40) and neutrophils (r = 0.38). Figure 4c shows that immune-related functions positively correlate with both checkpoint and T-cell costimulation (r = 0.86). Additionally, inflammation-promoting factors were positively associated with major histocompatibility complex I (r = 0.82). In contrast, there was a negative correlation between T-cell co-inhibition and the type-II interferon response (r = −0.10), and APC-costimulation was negatively correlated with human leukocyte antigen (r = −0.06) as shown in Figure 4c. The levels of macrophages, mast cells, neutrophils, Th1 cells, and Tfh were significantly higher in the PAH group than in the NC group, as depicted in Figure 5a. Moreover, the levels of APC-costimulation, checkpoint, para-inflammation, and T-cell stimulation expression were significantly higher in the PAH group than in the NC group, as illustrated in Figure 5b.

Figure 4 
                  Immune cell infiltration analysis in PAH. (a) Visualization of the distribution of immune cells and their functional roles in PAH using a heat map. (b) Immune cell correlation heat map. (b and c) Immune-related function heat map.
Figure 4

Immune cell infiltration analysis in PAH. (a) Visualization of the distribution of immune cells and their functional roles in PAH using a heat map. (b) Immune cell correlation heat map. (b and c) Immune-related function heat map.

Figure 5 
                  Distribution and visualization of immune cell infiltration. (a) Line plot depicting infiltration of immune cells. (b) Line plot showing immune-related function. (c) The correlation plot displays the correlation between the BM-related genes and immune cells as well as immune function (***P < 0.001, **P < 0.01, and *P < 0.5).
Figure 5

Distribution and visualization of immune cell infiltration. (a) Line plot depicting infiltration of immune cells. (b) Line plot showing immune-related function. (c) The correlation plot displays the correlation between the BM-related genes and immune cells as well as immune function (***P < 0.001, **P < 0.01, and *P < 0.5).

To better understand the relationship between hub genes and the infiltration of immune cells in PAH, we used Spearman to analyze the correlation between hub genes and immune cell infiltration levels. Figure 5c shows a positive correlation between ITGA9 and mast cells (r = 0.48), and a negative correlation with macrophages, neutrophils, and T-cell co-inhibition (r = −0.52, −0.46, −0.45). ITGA2 showed a positive correlation with APC-costimulation, chemokine receptor (CCR), checkpoint, para-inflammation, Th1 cells, and Treg immune cells. There was an inverse relationship between para-inflammation (r = −0.56) and checkpoint (r = −0.44) with ITGA10. ITGA4 had positive correlations with checkpoint (r = 0.68), T-cell costimulation (r = 0.60), and TIL (r = 0.58). COL4A3 is positively associated with the immune cell type mast cells (r = 0.47) and was found to have a negative correlation with macrophages (r = −0.56). There was a positive correlation (r = 0.41) between THBS2 and immunological function para-inflammation. There was a positive correlation (r = 0.64) between immune cell CCR and THBS1, but THBS1 had a negative correlation (r = −0.59) with Treg. There was a positive relationship found between ITGAV and the immune cell types of Treg (r = 0.45) and Th1 cells (r = 0.41). Based on the results mentioned above, it is suggested that the hub gene plays a crucial role in regulating immune cell activity and responses in the immune system.

3.5 Construction and validation of nomogram

To assess the effect of hub gene on PAH patients, we established a nomogram to predict the association between hub gene expression and survival in PAH patients. The model included the expression patterns of six BM-DEGs namely ITGAV, ITGA4, ITGA9, THBS1, ITGA2, and COL4A3. It also made use of the expression levels of six hub genes as variables, as illustrated in Figure 6a. The findings indicate that the nomogram predicted the area under the curve (AUC) value for the receiver operating characteristic curve (ROC) for PAH patients to be 0.934 (Figure 6b).

Figure 6 
                  A nomogram is presented to predict the relationship between expression of hub genes and survival rate among individuals with PAH. (a) Survival nomogram prediction model for PAH patients (b) ROC curve to evaluate the accuracy of PAH prediction by a nomogram model.
Figure 6

A nomogram is presented to predict the relationship between expression of hub genes and survival rate among individuals with PAH. (a) Survival nomogram prediction model for PAH patients (b) ROC curve to evaluate the accuracy of PAH prediction by a nomogram model.

3.6 Prediction of drug and miRNA targets for genes associated with the BM

We investigated possible therapeutic drugs for PAH that modify the hub gene by utilizing the Drug Signatures Database (DSigDB, http://tanlab.ucdenver.edu/DSigDB). A total of 361 target medications were identified. Table 2 displays the top 10 target medications, ranked by their composite score. To achieve a better understanding of the molecular basis of the six hub genes, we used the Enrichr database to predict their associated miRNAs. These hub genes were found to be associated with a total of 25 miRNAs. We used Cytoscape software, as shown in Figure 7, to build miRNA–mRNA networks.

Table 2

Drug prediction results of BM-associated genes

Term Adjust P-value Odds ratio Combined score
Clopidogrelum [Latin] CTD 00002343 0.003400 453.91 4896.92
58-64-0 CTD 00005321 0.003400 384.00 4022.15
Sulfinpyrazone TTD 00011126 0.04229 399.68 2284.21
Ginsenoside Rh1 CTD 00003920 0.04229 399.68 2284.21
Cortisolsuccinate CTD 00000336 0.04229 399.68 2284.21
Epinephrine CTD 00005907 0.007588 216.83 2034.63
Tesmilifene CTD 00001953 0.04229 333.03 1847.77
Phenylbutazone TTD 00010195 0.04229 307.40 1682.80
Raltitrexed CTD 00002721 0.04229 285.43 1542.87
8-iso Prostaglandin A2 CTD 00003317 0.04229 235.02 1227.64
Figure 7 
                  mRNA–miRNA regulatory network. A total of 25 miRNAs were anticipated to be linked with the hub genes.
Figure 7

mRNA–miRNA regulatory network. A total of 25 miRNAs were anticipated to be linked with the hub genes.

4 Discussion

Generally, the primary function of healthy pulmonary vessels is to uphold pulmonary circulation and facilitate lung gas exchange. Normal pulmonary vessels consist of ECs, intima, media, and adventitia structurally [8]. Vasodilation and smooth muscle relaxation are maintained by ECs through the production of nitric oxide, prostacyclin, and other factors [24]. The intima consists of smooth muscle cells that are sparsely arranged and can contribute to the regulation of vasoconstriction [25]. Elastic fibers make up the main component of the media layer, providing resistance to the distension and deformation of blood vessels. Fibroblasts and collagen are found in the adventitia layer, providing vascular support in terms of structure [26,27]. During the development of PAH, the normal vascular structure and function are gradually destroyed. PAH can be subdivided into three stages based on the progression of the disease: the compensatory stage, the decomposition stage, and the end stage [4]. During the compensatory phase of PAH, the pulmonary artery maintains vasodilation and low vascular tension. At the decompensation stage, pulmonary artery contraction worsened, and vascular reactivity decreased. Endothelial function became impaired, leading to a downregulation in the expression of nitric oxide synthase (eNOS). The proliferation of smooth muscle cells was evident. There is end-stage, severe, and irreversible pulmonary vasoconstriction and occlusion. The endothelium suffered severe damage, leading to a drastic reduction in eNOS expression and loss of the ability to synthesize prostacyclin. The proliferation of smooth muscle cells results in vascular stenosis. The blood vessels have lost almost all their reactivity [28]. Individual pulmonary vascular remodeling and changes in the BM are closely related to the development of PAH. Hence, it is crucial to determine the functions of DEGs in the BM of PAH patients to assess the severity of disease progression and suggest suitable treatment options.

This study examines two tissue microarray datasets (GSE117261 and GSE113439) of PAH from the GEO database, in conjunction with the analysis of BM-related genes, revealing DEGs between the PAH and NC groups. By constructing a PPI network, we identified the top 10 hub genes, including ITGAV, ITGB3, ITGA9, ITGB8, THBS2, ITGA4, ITGA2, ITGA10, COL4A3, and THBS1. These genes were mainly enriched in ECM organization, extracellular structure organization, collagen-containing ECM, BM, and ECM structural constituent. The ECM is a complex network of structural proteins like collagen and functional proteins like adhesion factors covering the cellular microenvironment. It actively participates in maintaining normal tissue structure and cell function [29]. ECM organization is the process of organizing the ECM, which includes synthesizing, depositing, and cross-linking matrix components. These processes collectively create a 3D microenvironment structure that promotes cell growth, migration, and function [30]. The study identified ECM organization as the most significant enrichment pathway, indicating that ECM remodeling may have a crucial role in this pathological process. Alterations in the expression and deposition patterns of matrix constituents may impact cell viability and tissue structure. The BM-DEGs were primarily enriched in myocardial infarction and osteosarcoma in DO. The KEGG enrichment analysis showed that BM-DEGs in PAH patients were mainly involved in ECM–receptor interaction, adhesion, human papillomavirus infection, the PI3K–Akt signaling pathway, and regulation of the actin cytoskeleton.

To better comprehend the role of immune cell infiltration in the development of PAH, we examined the correlation between immune cells, immune function, and DEGs in PAH with a focus on hub genes. The findings indicated that the hub gene could play an indirect role in the infiltration of immune cells in PAH by affecting immune cell CCR, T-cell costimulation, immune regulation pathways, checkpoints, and para-inflammation either directly or indirectly. This implies that the hub gene could influence the development of PAH. ITGAV located in the hub gene is expressed widely on the surface of connective tissue and immune cells. It may combine with various β-integrins to create a heterodimeric integrin that binds to ECM proteins, including fibronectin, osteocalcin, and fibronectin and contributes to cellular adhesion and migration [31]. Research has indicated that among patients with low-grade glioma, ITGAV mRNA expression levels are linked to tumor immunity, immune checkpoints, immune checkpoint blockade, and response to chemotherapy. An elevated expression of ITGAV is indicative of severe infiltration of inflammatory cells [32]. Integrin Alpha 4, also known as ITGA4, mediates the adhesion of lung tissue and the chemotactic migration of immune cells, including lymphocytes, monocytes, and neutrophils. Studies have found that ITGA4 is a crucial regulatory gene in the pathological process of systemic sclerosis-associated interstitial lung disease, which is associated with lung function [33]. A nomogram was created to forecast the correlation between hub genes and the incidence of PAH. The result’s accuracy improved with an AUC value of 0.934 for the ROC curve. An extensive network of interactions was established between miRNAs and hub genes to obtain a list of miRNAs and mRNAs. This process involved utilizing the Enrichr database to evaluate the six genes, leading to the identification of 25 miRNAs and 69 mRNA–miRNA pairs.

Among the six hub genes, ITGAV, ITGA4, ITGA9, and ITGA2 belong to the Integrin Alpha chain family. THBS1 is a glycoprotein gene, and COL4A3 is a gene for the Collagen Alpha 3 (IV) chain [34]. Integrin is a transmembrane receptor that plays a critical role in cell adhesion. Integrins connect the ECM with the cytoskeleton, facilitating the transmission of biochemical and mechanical signals between the cell and its surrounding environment [34]. In the development of pulmonary vascular remodeling leading to PAH, the following processes occur: various stimulating factors cause damage to pulmonary arterial vessels resulting in EC dysfunction and apoptosis during the early stages of PAH. As a result, vascular endothelial permeability increases, there is a massive aggregation of platelets and inflammatory factors, and pulmonary artery smooth muscle cells are activated. Smooth muscle cells proliferate and migrate uncontrollably, depositing in the intima and media of the blood vessels leading to thickening and hardening of the blood vessel wall. Simultaneously, damaged ECs release increasing amounts of pro-fibrotic factors. This causes abnormal proliferation of cells similar to myofibroblasts and excessive secretion of ECM. This resulted in a broken BM, which led to a large accumulation of collagen. Subsequently, the vascular wall became increasingly fibrotic. This gradual process leads to alterations in the structure and function of the pulmonary artery wall, further narrowing of the vascular lumen, and related hemodynamic changes. Subsequently, there is increased resistance of the pulmonary vascular system, which ultimately leads to the development of PAH [1,35]. The most prominent pathological characteristic is the significant hyperplasia of fibrous tissue in the intima of the pulmonary artery wall. Research on human patient samples and animal model studies has confirmed that numerous ECM components including, but not limited to, collagen, elastin, tenascin-c, and fibronectin are deposited in these hyperplastic fibrous tissues [36,37]. PAH caused by hypoxia is usually the major contributor to cardiovascular disease. The activation of the transforming growth factor-beta (TGF-β) signaling pathway is crucial for the development of hypoxic and other forms of PAH [38]. Studies conducted recently revealed that stability of HIF2α results in increased expression of a protein, thrombospondin-1 (TSP-1), which activates TGF-β [39]. Collagen type IV is a crucial constituent of the ECM including COL4A3 as one of its components [40]. To summarize, several genes related to the BM mentioned above possibly contribute to the development of PAH.

The abnormal growth and movement of endothelial and smooth muscle cells in the lungs of PAH patients is a significant pathological feature in the occurrence and development of PAH. Targeting the growth and movement of these cells has been considered an effective method to combat this situation and treat PAH. The published literature highlights the importance of the PI3K–Akt signaling pathway in the pathological progression of PAH [41]. The PI3K/Akt pathway’s role in promoting cell proliferation and survival has been extensively researched in various types of cells, including smooth muscle cells with abnormal proliferation [42]. Moreover, the possibility of treating PAH by targeting the mammalian target of rapamycin (mTOR) has been investigated. mTOR is a crucial downstream entity of the PI3K/Akt pathway, which takes part in cell proliferation, migration, differentiation, and protein synthesis [43]. Studies have shown that the hypoxia-induced PAH model indicates that stimulating the PI3K/Akt pathway may promote abnormal proliferation of smooth muscle cells [44]. Furthermore, regulation of the PI3K/Akt pathway may influence the apoptosis of these cells. Thus, these and the proposed findings allude to the PI3K/Akt signaling pathway indirectly influencing the incidence of PAH.

The study found that macrophages, mast cells, and Th1 cells played a crucial role in the progression of PAH through immune cell infiltration. Research has acknowledged that macrophages play an essential role in the development of pulmonary vascular disease and may also contribute to its severity [45]. Mast cells are the first immune cells observed in pulmonary vascular lesions in individuals with PAH. Upon activation, mast cells release cysteine leukotriene C4 and endothelin, leading to pulmonary vascular remodeling and the onset of PAH [16]. Th1 cells contribute to the development of atherosclerosis. Th1 cells secrete cytokines, leading to inflammation in atherosclerotic lesions, and promoting the formation of foam cells [46]. The literature has not reported any relationship between Th1 cells and PAH. Conversely, studies suggest that immune-related functions such as APC-costimulation, checkpoint, para-inflammation, and T-cell-costimulation play a significant role in PAH development. A correlation between immune infiltration and the presence of inflammatory BM in PAH patients was found in this study. Further exploration should be conducted on the creation of miRNA regulatory networks. Additional investigations are required to ascertain the potential of integrated immune-infiltration-based immune cell analysis and ceRNA network construction for identifying diagnostic markers that can advance clinical management and treatment options for PAH. Simultaneously, researchers have focused on examining the genes responsible for the pathological progression of the condition and discovering targeted therapies that are effective. Ginsenoside Rh1 is a notable instance. Studies have demonstrated the positive effects of ginsenoside Rh1 on myocardial remodeling and pulmonary hemodynamics in PAH patients [47]. However, further in vivo and in vitro experiments are necessary to validate its efficacy and safety.

Nevertheless, our study has some limitations. First, there is a scarcity of research studying the mechanisms that underlie the correlation between BM and PAH. In addition, the current research sample is limited, which may introduce potential bias. Although six hub genes related to the development of PAH have been identified, further experiments are required to confirm their regulatory role in the pathogenesis of PAH.


tel: +86 13407265011

  1. Funding information: Authors state no funding involved.

  2. Conflict of interest: Authors state no conflict of interest.

  3. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Ruopp NF, Cockrill BA. Diagnosis and treatment of pulmonary arterial hypertension: A review. JAMA. 2022;327(14):1379–91.10.1001/jama.2022.4402Search in Google Scholar PubMed

[2] Rivera SL, Martin J, Landry J. Acute and chronic hypertension: What clinicians need to know for diagnosis and management. Crit Care Nurs Clin North Am. 2019;31(1):97–108.10.1016/j.cnc.2018.11.008Search in Google Scholar PubMed

[3] Zahid KR, Raza U, Chen J, Raj UJ, Gou D. Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs. Cardiovasc Res. 2020;116(12):1937–47.10.1093/cvr/cvaa050Search in Google Scholar PubMed

[4] Luna-López R, Ruiz Martín A, Subías PE. Pulmonary arterial hypertension. Hipertensión arterial pulmonar. Med Clin (Barc). 2022;158(12):622–9.10.1016/j.medcli.2022.01.003Search in Google Scholar PubMed

[5] Pitre T, Su J, Cui S, Scanlan R, Chiang C, Husnudinov R, et al. Medications for the treatment of pulmonary arterial hypertension: A systematic review and network meta-analysis. Eur Respir Rev. 2022;31(165):220036.10.1183/16000617.0036-2022Search in Google Scholar PubMed PubMed Central

[6] D’Alto M, Naeije R. Pulmonary artery pressure-directed therapies in pulmonary arterial hypertension? Vascul Pharmacol. 2022;147:107124.10.1016/j.vph.2022.107124Search in Google Scholar PubMed

[7] Morris HE, Neves KB, Montezano AC, MacLean MR, Touyz RM. Notch3 signalling and vascular remodelling in pulmonary arterial hypertension. Clin Sci (Lond). 2019;133(24):2481–98.10.1042/CS20190835Search in Google Scholar PubMed PubMed Central

[8] Evans CE, Cober ND, Dai Z, Stewart DJ, Zhao YY. Endothelial cells in the pathogenesis of pulmonary arterial hypertension. Eur Respir J. 2021;58(3):2003957.10.1183/13993003.03957-2020Search in Google Scholar PubMed PubMed Central

[9] Hudson J, Farkas L. Epigenetic regulation of endothelial dysfunction and inflammation in pulmonary arterial hypertension. Int J Mol Sci. 2021;22(22):12098.10.3390/ijms222212098Search in Google Scholar PubMed PubMed Central

[10] Chakraborty A, de Jesus Perez VA. Hiding in plain sight: The basement membrane in pulmonary vascular remodeling. Am J Respir Cell Mol Biol. 2020;63(1):13–4.10.1165/rcmb.2020-0100EDSearch in Google Scholar PubMed PubMed Central

[11] Jandl K, Marsh LM, Hoffmann J, Mutgan AC, Baum O, Bloch W, et al. Basement membrane remodeling controls endothelial function in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2020;63(1):104–17.10.1165/rcmb.2019-0303OCSearch in Google Scholar PubMed

[12] Jandl K, Radic N, Zeder K, Kovacs G, Kwapiszewska G. Pulmonary vascular fibrosis in pulmonary hypertension – The role of the extracellular matrix as a therapeutic target. Pharmacol Ther. 2023;247:108438.10.1016/j.pharmthera.2023.108438Search in Google Scholar PubMed

[13] Mutgan AC, Jandl K, Kwapiszewska G. Endothelial basement membrane components and their products, Matrikines: Active drivers of pulmonary hypertension? Cells. 2020;9(9):2029.10.3390/cells9092029Search in Google Scholar PubMed PubMed Central

[14] Dong H, Li X, Cai M, Zhang C, Mao W, Wang Y, et al. Integrated bioinformatic analysis reveals the underlying molecular mechanism of and potential drugs for pulmonary arterial hypertension. Aging (Albany NY). 2021;13(10):14234–57.10.18632/aging.203040Search in Google Scholar PubMed PubMed Central

[15] Southgate L, Machado RD, Gräf S, Morrell NW. Molecular genetic framework underlying pulmonary arterial hypertension. Nat Rev Cardiol. 2020;17(2):85–95.10.1038/s41569-019-0242-xSearch in Google Scholar PubMed

[16] Hu Y, Chi L, Kuebler WM, Goldenberg NM. Perivascular Inflammation in Pulmonary Arterial Hypertension. Cells. 2020;9(11):2338.10.3390/cells9112338Search in Google Scholar PubMed PubMed Central

[17] Willson C, Watanabe M, Tsuji-Hosokawa A, Makino A. Pulmonary vascular dysfunction in metabolic syndrome. J Physiol. 2019;597(4):1121–41.10.1113/JP275856Search in Google Scholar PubMed PubMed Central

[18] Ma Y, Chen SS, Feng YY, Wang HL. Identification of novel biomarkers involved in pulmonary arterial hypertension based on multiple-microarray analysis. Biosci Rep. 2020;40(9):BSR20202346.10.1042/BSR20202346Search in Google Scholar PubMed PubMed Central

[19] Jayadev R, Morais MRPT, Ellingford JM, Srinivasan S, Naylor RW, Lawless C, et al. A basement membrane discovery pipeline uncovers network complexity, regulators, and human disease associations. Sci Adv. 2022;8(20):eabn2265.10.1126/sciadv.abn2265Search in Google Scholar PubMed PubMed Central

[20] Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605–12.10.1093/nar/gkaa1074Search in Google Scholar PubMed PubMed Central

[21] Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape StringApp: Network analysis and visualization of proteomics data. J Proteome Res. 2019;18(2):623–32.10.1021/acs.jproteome.8b00702Search in Google Scholar PubMed PubMed Central

[22] Jin Y, Wang Z, He D, Zhu Y, Chen X, Cao K. Identification of novel subtypes based on ssGSEA in immune-related prognostic signature for tongue squamous cell carcinoma. Cancer Med. 2021;10(23):8693–707.10.1002/cam4.4341Search in Google Scholar PubMed PubMed Central

[23] Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, et al. Gene set knowledge discovery with Enrichr. Curr Protoc. 2021;1(3):e90.10.1002/cpz1.90Search in Google Scholar PubMed PubMed Central

[24] Niethamer TK, Stabler CT, Leach JP, Zepp JA, Morley MP, Babu A, et al. Defining the role of pulmonary endothelial cell heterogeneity in the response to acute lung injury. Elife. 2020;9:e53072.10.7554/eLife.53072Search in Google Scholar PubMed PubMed Central

[25] Liu M, Gomez D. Smooth muscle cell phenotypic diversity. Arterioscler Thromb Vasc Biol. 2019;39(9):1715–23.10.1161/ATVBAHA.119.312131Search in Google Scholar PubMed PubMed Central

[26] Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest. 2012;122(12):4306–13.10.1172/JCI60658Search in Google Scholar PubMed PubMed Central

[27] Tuder RM. Pulmonary vascular remodeling in pulmonary hypertension. Cell Tissue Res. 2017;367(3):643–9.10.1007/s00441-016-2539-ySearch in Google Scholar PubMed PubMed Central

[28] Cober ND, VandenBroek MM, Ormiston ML, Stewart DJ. Evolving concepts in endothelial pathobiology of pulmonary arterial hypertension. Hypertension. 2022;79(8):1580–90.10.1161/HYPERTENSIONAHA.122.18261Search in Google Scholar PubMed

[29] Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK. Extracellular matrix structure. Adv Drug Deliv Rev. 2016;97:4–27.10.1016/j.addr.2015.11.001Search in Google Scholar PubMed

[30] Karamanos NK, Theocharis AD, Piperigkou Z, Manou D, Passi A, Skandalis SS, et al. A guide to the composition and functions of the extracellular matrix. FEBS J. 2021;288(24):6850–912.10.1111/febs.15776Search in Google Scholar PubMed

[31] Endo I, Amatya VJ, Kushitani K, Nakagiri T, Aoe K, Takeshima Y. miR-142-3p suppresses invasion and adhesion of mesothelioma cells by downregulating ITGAV. Pathobiology. 2023;90(4):270–80.10.1159/000528670Search in Google Scholar PubMed

[32] Tan Z, Zhang Z, Yu K, Yang H, Liang H, Lu T, et al. Integrin subunit alpha V is a potent prognostic biomarker associated with immune infiltration in lower-grade glioma. Front Neurol. 2022;13:964590.10.3389/fneur.2022.964590Search in Google Scholar PubMed PubMed Central

[33] Jung SM, Park KS, Kim KJ. Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease. Ann Rheum Dis. 2022;81(1):108–16.10.1136/annrheumdis-2021-220493Search in Google Scholar PubMed

[34] Pang X, He X, Qiu Z, Zhang H, Xie R, Liu Z, et al. Targeting integrin pathways: mechanisms and advances in therapy. Signal Transduct Target Ther. 2023;8(1):1.10.1038/s41392-022-01259-6Search in Google Scholar PubMed PubMed Central

[35] Hassoun PM. Pulmonary arterial hypertension. N Engl J Med. 2021;385(25):2361–76.10.1056/NEJMra2000348Search in Google Scholar PubMed

[36] Gorelova A, Berman M, Al Ghouleh I. Endothelial-to-mesenchymal transition in pulmonary arterial hypertension. Antioxid Redox Signal. 2021;34(12):891–914.10.1089/ars.2020.8169Search in Google Scholar PubMed PubMed Central

[37] Jandl K, Marsh LM, Mutgan AC, Crnkovic S, Valzano F, Zabini D, et al. Impairment of the NKT-STAT1-CXCL9 Axis contributes to vessel fibrosis in pulmonary hypertension caused by lung fibrosis. Am J Respir Crit Care Med. 2022;206(8):981–98.10.1164/rccm.202201-0142OCSearch in Google Scholar PubMed

[38] Guignabert C, Humbert M. Targeting transforming growth factor-β receptors in pulmonary hypertension. Eur Respir J. 2021;57(2):2002341.10.1183/13993003.02341-2020Search in Google Scholar PubMed

[39] Yang Z, Li T, Xian J, Chen J, Huang Y, Zhang Q, et al. SGLT2 inhibitor dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the HIF-2α signaling pathway in arrhythmogenic cardiomyopathy. FASEB J. 2022;36(7):e22410.10.1096/fj.202200243RSearch in Google Scholar PubMed

[40] Kisling A, Lust RM, Katwa LC. What is the role of peptide fragments of collagen I and IV in health and disease? Life Sci. 2019;228:30–4.10.1016/j.lfs.2019.04.042Search in Google Scholar PubMed

[41] Yang HT, Wang G, Zhu PC, Xiao ZY. Silencing EIF3A ameliorates pulmonary arterial hypertension through HDAC1 and PTEN/PI3K/AKT pathway in vitro and in vivo. Exp Cell Res. 2023;426(1):113555.10.1016/j.yexcr.2023.113555Search in Google Scholar PubMed

[42] Song BW, Lee CY, Park JH, Kim B, Lee S, Lim S, et al. Cold-pressed oil from Citrus aurantifolia inhibits the proliferation of vascular smooth muscle cells via regulation of PI3K/MAPK signaling pathways. Exp Ther Med. 2022;23(1):21.10.3892/etm.2021.10943Search in Google Scholar PubMed PubMed Central

[43] Ahmad I, Hoque M, Alam SSM, Zughaibi TA, Tabrez S. Curcumin and plumbagin synergistically target the PI3K/Akt/mTOR pathway: A prospective role in cancer treatment. Int J Mol Sci. 2023;24(7):6651.10.3390/ijms24076651Search in Google Scholar PubMed PubMed Central

[44] Jain PP, Lai N, Xiong M, Chen J, Babicheva A, Zhao T, et al. TRPC6, a therapeutic target for pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2021;321(6):L1161–82.10.1152/ajplung.00159.2021Search in Google Scholar PubMed PubMed Central

[45] Florentin J, Coppin E, Vasamsetti SB, Zhao J, Tai YY, Tang Y, et al. Inflammatory macrophage expansion in pulmonary hypertension depends upon mobilization of blood-borne monocytes. J Immunol. 2018;200(10):3612–25.10.4049/jimmunol.1701287Search in Google Scholar PubMed PubMed Central

[46] Chen J, Xiang X, Nie L, Guo X, Zhang F, Wen C, et al. The emerging role of Th1 cells in atherosclerosis and its implications for therapy. Front Immunol. 2023;13:1079668.10.3389/fimmu.2022.1079668Search in Google Scholar PubMed PubMed Central

[47] Tang BL, Liu Y, Zhang JL, Lu ML, Wang HX Ginsenoside Rg1 ameliorates hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and inflammation by regulating CCN1. Biomed Pharmacother. 2023;164:114920.10.1016/j.biopha.2023.114920Search in Google Scholar PubMed

Received: 2023-06-15
Revised: 2023-08-07
Accepted: 2023-08-26
Published Online: 2023-09-26

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
  3. Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
  4. Identifying two pathogenic variants in a patient with pigmented paravenous retinochoroidal atrophy
  5. Effects of phytoestrogens combined with cold stress on sperm parameters and testicular proteomics in rats
  6. A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection
  7. Neutrophilia with subclinical Cushing’s disease: A case report and literature review
  8. Isoimperatorin alleviates lipopolysaccharide-induced periodontitis by downregulating ERK1/2 and NF-κB pathways
  9. Immunoregulation of synovial macrophages for the treatment of osteoarthritis
  10. Novel CPLANE1 c.8948dupT (p.P2984Tfs*7) variant in a child patient with Joubert syndrome
  11. Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
  12. Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
  13. High glucose and high lipid induced mitochondrial dysfunction in JEG-3 cells through oxidative stress
  14. Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth
  15. Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
  16. Age-related changes in peripheral T-cell subpopulations in elderly individuals: An observational study
  17. Single-cell transcription analysis reveals the tumor origin and heterogeneity of human bilateral renal clear cell carcinoma
  18. Identification of iron metabolism-related genes as diagnostic signatures in sepsis by blood transcriptomic analysis
  19. Long noncoding RNA ACART knockdown decreases 3T3-L1 preadipocyte proliferation and differentiation
  20. Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report
  21. Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
  22. Soy isoflavone reduces LPS-induced acute lung injury via increasing aquaporin 1 and aquaporin 5 in rats
  23. Refractory hypokalemia with sexual dysplasia and infertility caused by 17α-hydroxylase deficiency and triple X syndrome: A case report
  24. Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
  25. 6-Phosphogluconate dehydrogenase inhibition arrests growth and induces apoptosis in gastric cancer via AMPK activation and oxidative stress
  26. Experimental study on the optimization of ANM33 release in foam cells
  27. Primary retroperitoneal angiosarcoma: A case report
  28. Metabolomic analysis-identified 2-hydroxybutyric acid might be a key metabolite of severe preeclampsia
  29. Malignant pleural effusion diagnosis and therapy
  30. Effect of spaceflight on the phenotype and proteome of Escherichia coli
  31. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis
  32. Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation
  33. Association between the VEGFR-2 -604T/C polymorphism (rs2071559) and type 2 diabetic retinopathy
  34. The role of IL-31 and IL-34 in the diagnosis and treatment of chronic periodontitis
  35. Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features
  36. mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study
  37. The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
  38. Radiotherapy for primary thyroid adenoid cystic carcinoma
  39. Design and functional preliminary investigation of recombinant antigen EgG1Y162–EgG1Y162 against Echinococcus granulosus
  40. Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
  41. Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics
  42. Performance comparison of three scaling algorithms in NMR-based metabolomics analysis
  43. PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer
  44. The altered expression of cytoskeletal and synaptic remodeling proteins during epilepsy
  45. Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor
  46. Prostatitis as initial manifestation of Chlamydia psittaci pneumonia diagnosed by metagenome next-generation sequencing: A case report
  47. NUDT21 relieves sevoflurane-induced neurological damage in rats by down-regulating LIMK2
  48. Association of interleukin-10 rs1800896, rs1800872, and interleukin-6 rs1800795 polymorphisms with squamous cell carcinoma risk: A meta-analysis
  49. Exosomal HBV-DNA for diagnosis and treatment monitoring of chronic hepatitis B
  50. Shear stress leads to the dysfunction of endothelial cells through the Cav-1-mediated KLF2/eNOS/ERK signaling pathway under physiological conditions
  51. Interaction between the PI3K/AKT pathway and mitochondrial autophagy in macrophages and the leukocyte count in rats with LPS-induced pulmonary infection
  52. Meta-analysis of the rs231775 locus polymorphism in the CTLA-4 gene and the susceptibility to Graves’ disease in children
  53. Cloning, subcellular localization and expression of phosphate transporter gene HvPT6 of hulless barley
  54. Coptisine mitigates diabetic nephropathy via repressing the NRLP3 inflammasome
  55. Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis
  56. Whole-exome sequencing applications in prenatal diagnosis of fetal bowel dilatation
  57. Gemella morbillorum infective endocarditis: A case report and literature review
  58. An unusual ectopic thymoma clonal evolution analysis: A case report
  59. Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
  60. Detection of V. vulnificus septic shock with ARDS using mNGS
  61. Novel rare genetic variants of familial and sporadic pulmonary atresia identified by whole-exome sequencing
  62. The influence and mechanistic action of sperm DNA fragmentation index on the outcomes of assisted reproduction technology
  63. Novel compound heterozygous mutations in TELO2 in an infant with You-Hoover-Fong syndrome: A case report and literature review
  64. ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
  65. Diagnosis of primary amoebic meningoencephalitis by metagenomic next-generation sequencing: A case report
  66. Phylogenetic analysis of promoter regions of human Dolichol kinase (DOLK) and orthologous genes using bioinformatics tools
  67. Collagen changes in rabbit conjunctiva after conjunctival crosslinking
  68. Effects of NM23 transfection of human gastric carcinoma cells in mice
  69. Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia
  70. Case report of hepatic retiform hemangioendothelioma: A rare tumor treated with ultrasound-guided microwave ablation
  71. Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling
  72. Rare presentation of double-clonal Waldenström macroglobulinemia with pulmonary embolism: A case report
  73. Giant duplication of the transverse colon in an adult: A case report and literature review
  74. Ectopic thyroid tissue in the breast: A case report
  75. SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer
  76. Vaginal metastasis from breast cancer: A case report
  77. Screening of the best time window for MSC transplantation to treat acute myocardial infarction with SDF-1α antibody-loaded targeted ultrasonic microbubbles: An in vivo study in miniswine
  78. Inhibition of TAZ impairs the migration ability of melanoma cells
  79. Molecular complexity analysis of the diagnosis of Gitelman syndrome in China
  80. Effects of maternal calcium and protein intake on the development and bone metabolism of offspring mice
  81. Identification of winter wheat pests and diseases based on improved convolutional neural network
  82. Ultra-multiplex PCR technique to guide treatment of Aspergillus-infected aortic valve prostheses
  83. Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
  84. Immune checkpoint inhibitors in cancer patients with COVID-19
  85. Utility of methylene blue mixed with autologous blood in preoperative localization of pulmonary nodules and masses
  86. Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
  87. Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
  88. DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
  89. Lung abscess by Fusobacterium nucleatum and Streptococcus spp. co-infection by mNGS: A case series
  90. Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
  91. Granulomatous polyangiitis involving the fourth ventricle: Report of a rare case and a literature review
  92. Studying infant mortality: A demographic analysis based on data mining models
  93. Metaplastic breast carcinoma with osseous differentiation: A report of a rare case and literature review
  94. Protein Z modulates the metastasis of lung adenocarcinoma cells
  95. Inhibition of pyroptosis and apoptosis by capsaicin protects against LPS-induced acute kidney injury through TRPV1/UCP2 axis in vitro
  96. TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
  97. Primary mediastinum Ewing’s sarcoma with pleural effusion: A case report and literature review
  98. Association of ADRB2 gene polymorphisms and intestinal microbiota in Chinese Han adolescents
  99. Tanshinone IIA alleviates chondrocyte apoptosis and extracellular matrix degeneration by inhibiting ferroptosis
  100. Study on the cytokines related to SARS-Cov-2 in testicular cells and the interaction network between cells based on scRNA-seq data
  101. Effect of periostin on bone metabolic and autophagy factors during tooth eruption in mice
  102. HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy
  103. Intravaginal estrogen management in postmenopausal patients with vaginal squamous intraepithelial lesions along with CO2 laser ablation: A retrospective study
  104. Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
  105. Effects of physical exercise on biomarkers of oxidative stress in healthy subjects: A meta-analysis of randomized controlled trials
  106. Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer
  107. Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2
  108. Research progress on gas signal molecular therapy for Parkinson’s disease
  109. Adiponectin inhibits TGF-β1-induced skin fibroblast proliferation and phenotype transformation via the p38 MAPK signaling pathway
  110. The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma
  111. α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
  112. CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
  113. Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
  114. Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction
  115. Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression
  116. Research progress of AMP-activated protein kinase and cardiac aging
  117. TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5
  118. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
  119. Metastasis from small cell lung cancer to ovary: A case report
  120. The early diagnosis and pathogenic mechanisms of sepsis-related acute kidney injury
  121. The effect of NK cell therapy on sepsis secondary to lung cancer: A case report
  122. Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation
  123. Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features
  124. Signalling pathways in the osteogenic differentiation of periodontal ligament stem cells
  125. Crosstalk between lactic acid and immune regulation and its value in the diagnosis and treatment of liver failure
  126. Clinicopathological features and differential diagnosis of gastric pleomorphic giant cell carcinoma
  127. Traumatic brain injury and rTMS-ERPs: Case report and literature review
  128. Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling
  129. Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2
  130. The co-expression pattern of VEGFR-2 with indicators related to proliferation, apoptosis, and differentiation of anagen hair follicles
  131. Inflammation-related signaling pathways in tendinopathy
  132. CD4+ T cell count in HIV/TB co-infection and co-occurrence with HL: Case report and literature review
  133. Clinical analysis of severe Chlamydia psittaci pneumonia: Case series study
  134. Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
  135. Influence of MTHFR polymorphism, alone or in combination with smoking and alcohol consumption, on cancer susceptibility
  136. Catharanthus roseus (L.) G. Don counteracts the ampicillin resistance in multiple antibiotic-resistant Staphylococcus aureus by downregulation of PBP2a synthesis
  137. Combination of a bronchogenic cyst in the thoracic spinal canal with chronic myelocytic leukemia
  138. Bacterial lipoprotein plays an important role in the macrophage autophagy and apoptosis induced by Salmonella typhimurium and Staphylococcus aureus
  139. TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data
  140. Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
  141. Ferroptosis: A potential target of macrophages in plaque vulnerability
  142. Predicting pediatric Crohn's disease based on six mRNA-constructed risk signature using comprehensive bioinformatic approaches
  143. Applications of genetic code expansion and photosensitive UAAs in studying membrane proteins
  144. HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway
  145. IL-17 in osteoarthritis: A narrative review
  146. Circadian cycle and neuroinflammation
  147. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis
  148. Hemorrhagic meningioma with pulmonary metastasis: Case report and literature review
  149. SPOP regulates the expression profiles and alternative splicing events in human hepatocytes
  150. Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
  151. PTX3 promotes IVIG resistance-induced endothelial injury in Kawasaki disease by regulating the NF-κB pathway
  152. Pancreatic ectopic thyroid tissue: A case report and analysis of literature
  153. The prognostic impact of body mass index on female breast cancer patients in underdeveloped regions of northern China differs by menopause status and tumor molecular subtype
  154. Report on a case of liver-originating malignant melanoma of unknown primary
  155. Case report: Herbal treatment of neutropenic enterocolitis after chemotherapy for breast cancer
  156. The fibroblast growth factor–Klotho axis at molecular level
  157. Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
  158. A case report of diagnosis and dynamic monitoring of Listeria monocytogenes meningitis with NGS
  159. Effect of autologous platelet-rich plasma on new bone formation and viability of a Marburg bone graft
  160. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
  161. Continuous non-adherent culture promotes transdifferentiation of human adipose-derived stem cells into retinal lineage
  162. Nrf3 alleviates oxidative stress and promotes the survival of colon cancer cells by activating AKT/BCL-2 signal pathway
  163. Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report
  164. Case report of atypical undernutrition of hypoproteinemia type
  165. Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer
  166. Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis
  167. Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma
  168. Clinicopathological characteristics of co-existing or mixed colorectal cancer and neuroendocrine tumor: Report of five cases
  169. Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
  170. Precisional detection of lymph node metastasis using tFCM in colorectal cancer
  171. Advances in diagnosis and treatment of perimenopausal syndrome
  172. A study of forensic genetics: ITO index distribution and kinship judgment between two individuals
  173. Acute lupus pneumonitis resembling miliary tuberculosis: A case-based review
  174. Plasma levels of CD36 and glutathione as biomarkers for ruptured intracranial aneurysm
  175. Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
  176. Novel risk prediction models for deep vein thrombosis after thoracotomy and thoracoscopic lung cancer resections, involving coagulation and immune function
  177. Exploring the diagnostic markers of essential tremor: A study based on machine learning algorithms
  178. Evaluation of effects of small-incision approach treatment on proximal tibia fracture by deep learning algorithm-based magnetic resonance imaging
  179. An online diagnosis method for cancer lesions based on intelligent imaging analysis
  180. Medical imaging in rheumatoid arthritis: A review on deep learning approach
  181. Predictive analytics in smart healthcare for child mortality prediction using a machine learning approach
  182. Utility of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in predicting acute-on-chronic liver failure survival
  183. A biomedical decision support system for meta-analysis of bilateral upper-limb training in stroke patients with hemiplegia
  184. TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
  185. Stochastic gradient descent optimisation for convolutional neural network for medical image segmentation
  186. Comparison of the prognostic value of four different critical illness scores in patients with sepsis-induced coagulopathy
  187. Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development
  188. Hepatobiliary surgery based on intelligent image segmentation technology
  189. Value of brain injury-related indicators based on neural network in the diagnosis of neonatal hypoxic-ischemic encephalopathy
  190. Analysis of early diagnosis methods for asymmetric dementia in brain MR images based on genetic medical technology
  191. Early diagnosis for the onset of peri-implantitis based on artificial neural network
  192. Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
  193. Forecast of pain degree of lumbar disc herniation based on back propagation neural network
  194. SPA-UNet: A liver tumor segmentation network based on fused multi-scale features
  195. Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image
  196. Rehabilitation effect of intelligent rehabilitation training system on hemiplegic limb spasms after stroke
  197. A novel approach for minimising anti-aliasing effects in EEG data acquisition
  198. ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
  199. Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model
  200. Lung nodule segmentation via semi-residual multi-resolution neural networks
  201. Evaluation of brain nerve function in ICU patients with Delirium by deep learning algorithm-based resting state MRI
  202. A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis
  203. Markov model combined with MR diffusion tensor imaging for predicting the onset of Alzheimer’s disease
  204. Effectiveness of the treatment of depression associated with cancer and neuroimaging changes in depression-related brain regions in patients treated with the mediator-deuterium acupuncture method
  205. Molecular mechanism of colorectal cancer and screening of molecular markers based on bioinformatics analysis
  206. Monitoring and evaluation of anesthesia depth status data based on neuroscience
  207. Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X + S768I mutations in non-small cell lung cancer: An in silico approaches
  208. Optimised feature selection-driven convolutional neural network using gray level co-occurrence matrix for detection of cervical cancer
  209. Incidence of different pressure patterns of spinal cerebellar ataxia and analysis of imaging and genetic diagnosis
  210. Pathogenic bacteria and treatment resistance in older cardiovascular disease patients with lung infection and risk prediction model
  211. Adoption value of support vector machine algorithm-based computed tomography imaging in the diagnosis of secondary pulmonary fungal infections in patients with malignant hematological disorders
  212. From slides to insights: Harnessing deep learning for prognostic survival prediction in human colorectal cancer histology
  213. Ecology and Environmental Science
  214. Monitoring of hourly carbon dioxide concentration under different land use types in arid ecosystem
  215. Comparing the differences of prokaryotic microbial community between pit walls and bottom from Chinese liquor revealed by 16S rRNA gene sequencing
  216. Effects of cadmium stress on fruits germination and growth of two herbage species
  217. Bamboo charcoal affects soil properties and bacterial community in tea plantations
  218. Optimization of biogas potential using kinetic models, response surface methodology, and instrumental evidence for biodegradation of tannery fleshings during anaerobic digestion
  219. Understory vegetation diversity patterns of Platycladus orientalis and Pinus elliottii communities in Central and Southern China
  220. Studies on macrofungi diversity and discovery of new species of Abortiporus from Baotianman World Biosphere Reserve
  221. Food Science
  222. Effect of berrycactus fruit (Myrtillocactus geometrizans) on glutamate, glutamine, and GABA levels in the frontal cortex of rats fed with a high-fat diet
  223. Guesstimate of thymoquinone diversity in Nigella sativa L. genotypes and elite varieties collected from Indian states using HPTLC technique
  224. Analysis of bacterial community structure of Fuzhuan tea with different processing techniques
  225. Untargeted metabolomics reveals sour jujube kernel benefiting the nutritional value and flavor of Morchella esculenta
  226. Mycobiota in Slovak wine grapes: A case study from the small Carpathians wine region
  227. Elemental analysis of Fadogia ancylantha leaves used as a nutraceutical in Mashonaland West Province, Zimbabwe
  228. Microbiological transglutaminase: Biotechnological application in the food industry
  229. Influence of solvent-free extraction of fish oil from catfish (Clarias magur) heads using a Taguchi orthogonal array design: A qualitative and quantitative approach
  230. Chromatographic analysis of the chemical composition and anticancer activities of Curcuma longa extract cultivated in Palestine
  231. The potential for the use of leghemoglobin and plant ferritin as sources of iron
  232. Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM
  233. Bioengineering and Biotechnology
  234. Biocompatibility and osteointegration capability of β-TCP manufactured by stereolithography 3D printing: In vitro study
  235. Clinical characteristics and the prognosis of diabetic foot in Tibet: A single center, retrospective study
  236. Agriculture
  237. Biofertilizer and NPSB fertilizer application effects on nodulation and productivity of common bean (Phaseolus vulgaris L.) at Sodo Zuria, Southern Ethiopia
  238. On correlation between canopy vegetation and growth indexes of maize varieties with different nitrogen efficiencies
  239. Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia
  240. A transcriptomic evaluation of the mechanism of programmed cell death of the replaceable bud in Chinese chestnut
  241. Melatonin enhances salt tolerance in sorghum by modulating photosynthetic performance, osmoregulation, antioxidant defense, and ion homeostasis
  242. Effects of plant density on alfalfa (Medicago sativa L.) seed yield in western Heilongjiang areas
  243. Identification of rice leaf diseases and deficiency disorders using a novel DeepBatch technique
  244. Artificial intelligence and internet of things oriented sustainable precision farming: Towards modern agriculture
  245. Animal Sciences
  246. Effect of ketogenic diet on exercise tolerance and transcriptome of gastrocnemius in mice
  247. Combined analysis of mRNA–miRNA from testis tissue in Tibetan sheep with different FecB genotypes
  248. Isolation, identification, and drug resistance of a partially isolated bacterium from the gill of Siniperca chuatsi
  249. Tracking behavioral changes of confined sows from the first mating to the third parity
  250. The sequencing of the key genes and end products in the TLR4 signaling pathway from the kidney of Rana dybowskii exposed to Aeromonas hydrophila
  251. Development of a new candidate vaccine against piglet diarrhea caused by Escherichia coli
  252. Plant Sciences
  253. Crown and diameter structure of pure Pinus massoniana Lamb. forest in Hunan province, China
  254. Genetic evaluation and germplasm identification analysis on ITS2, trnL-F, and psbA-trnH of alfalfa varieties germplasm resources
  255. Tissue culture and rapid propagation technology for Gentiana rhodantha
  256. Effects of cadmium on the synthesis of active ingredients in Salvia miltiorrhiza
  257. Cloning and expression analysis of VrNAC13 gene in mung bean
  258. Chlorate-induced molecular floral transition revealed by transcriptomes
  259. Effects of warming and drought on growth and development of soybean in Hailun region
  260. Effects of different light conditions on transient expression and biomass in Nicotiana benthamiana leaves
  261. Comparative analysis of the rhizosphere microbiome and medicinally active ingredients of Atractylodes lancea from different geographical origins
  262. Distinguish Dianthus species or varieties based on chloroplast genomes
  263. Comparative transcriptomes reveal molecular mechanisms of apple blossoms of different tolerance genotypes to chilling injury
  264. Study on fresh processing key technology and quality influence of Cut Ophiopogonis Radix based on multi-index evaluation
  265. An advanced approach for fig leaf disease detection and classification: Leveraging image processing and enhanced support vector machine methodology
  266. Erratum
  267. Erratum to “Protein Z modulates the metastasis of lung adenocarcinoma cells”
  268. Erratum to “BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells”
  269. Retraction
  270. Retraction to “Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats”
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0730/html
Scroll to top button